JP2023537290A5 - - Google Patents
Info
- Publication number
- JP2023537290A5 JP2023537290A5 JP2023505990A JP2023505990A JP2023537290A5 JP 2023537290 A5 JP2023537290 A5 JP 2023537290A5 JP 2023505990 A JP2023505990 A JP 2023505990A JP 2023505990 A JP2023505990 A JP 2023505990A JP 2023537290 A5 JP2023537290 A5 JP 2023537290A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- administered
- day
- azacitidine
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063059419P | 2020-07-31 | 2020-07-31 | |
| US63/059,419 | 2020-07-31 | ||
| EP20195633.1 | 2020-09-11 | ||
| EP20195633 | 2020-09-11 | ||
| PCT/EP2021/071368 WO2022023514A1 (en) | 2020-07-31 | 2021-07-30 | Combination of a bcl-2 inhibitor and a hypomethylating agent for treating cancers, uses and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023537290A JP2023537290A (ja) | 2023-08-31 |
| JP2023537290A5 true JP2023537290A5 (https=) | 2024-08-07 |
Family
ID=77595496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505990A Withdrawn JP2023537290A (ja) | 2020-07-31 | 2021-07-30 | 癌を処置するためのＢｃｌ－２阻害薬と低メチル化剤との組合せ、その使用及び医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230270748A1 (https=) |
| EP (1) | EP4188387A1 (https=) |
| JP (1) | JP2023537290A (https=) |
| KR (1) | KR20230044452A (https=) |
| CN (1) | CN116390735A (https=) |
| AU (1) | AU2021316674A1 (https=) |
| BR (1) | BR112023001307A2 (https=) |
| CA (1) | CA3190276A1 (https=) |
| CL (1) | CL2023000242A1 (https=) |
| CR (1) | CR20230046A (https=) |
| IL (1) | IL300145A (https=) |
| JO (1) | JOP20230013A1 (https=) |
| MX (1) | MX2023001335A (https=) |
| PH (1) | PH12023550205A1 (https=) |
| WO (1) | WO2022023514A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025252168A1 (zh) * | 2024-06-06 | 2025-12-11 | 苏州亚盛药业有限公司 | 一种含有Bcl-2/Bcl-xL抑制剂的药物组合及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3008975A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU2017300738A1 (en) * | 2016-07-22 | 2019-02-07 | Les Laboratoires Servier | Combination of a BCL-2 inhibitor and a MCL-1 inhibitor, uses and pharmaceutical compositions thereof |
| UY38431A (es) | 2018-10-31 | 2020-05-29 | Servier Lab | Formulación basada en ciclodextrina de un inhibidor de bcl-2 |
| SI3873894T1 (sl) | 2018-10-31 | 2023-08-31 | Les Laboratoires Servier | Nova sol Bcl-2 inhibitorja, z njo povezana kristalna oblika, postopek za pripravo le-teh in farmacevtski sestavki, ki jih vsebujejo |
-
2021
- 2021-07-30 EP EP21763238.9A patent/EP4188387A1/en not_active Withdrawn
- 2021-07-30 JP JP2023505990A patent/JP2023537290A/ja not_active Withdrawn
- 2021-07-30 CR CR20230046A patent/CR20230046A/es unknown
- 2021-07-30 IL IL300145A patent/IL300145A/en unknown
- 2021-07-30 US US18/007,321 patent/US20230270748A1/en active Pending
- 2021-07-30 KR KR1020237006112A patent/KR20230044452A/ko active Pending
- 2021-07-30 CN CN202180066875.XA patent/CN116390735A/zh not_active Withdrawn
- 2021-07-30 BR BR112023001307A patent/BR112023001307A2/pt unknown
- 2021-07-30 CA CA3190276A patent/CA3190276A1/en active Pending
- 2021-07-30 PH PH1/2023/550205A patent/PH12023550205A1/en unknown
- 2021-07-30 MX MX2023001335A patent/MX2023001335A/es unknown
- 2021-07-30 AU AU2021316674A patent/AU2021316674A1/en not_active Abandoned
- 2021-07-30 WO PCT/EP2021/071368 patent/WO2022023514A1/en not_active Ceased
-
2023
- 2023-01-18 JO JOJO/P/2023/0013A patent/JOP20230013A1/ar unknown
- 2023-01-25 CL CL2023000242A patent/CL2023000242A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545835A5 (https=) | ||
| JP2024507938A5 (https=) | ||
| JP2024516795A5 (https=) | ||
| JP2023541432A5 (https=) | ||
| JP2023541430A5 (https=) | ||
| JP2022520061A5 (https=) | ||
| JP2007534730A (ja) | 少なくとも一つのピロロベンゾジアゼピン誘導体とフルダラビンとを含有する治療用組成物 | |
| RU2013102398A (ru) | Лечение рака крови | |
| JP2024516363A5 (https=) | ||
| JP2017031160A5 (https=) | ||
| JP2019526595A5 (https=) | ||
| TW200533339A (en) | Therapeutic synergy of anti-cancer compounds | |
| JP2024520900A5 (https=) | ||
| JP2021522247A5 (https=) | ||
| JP2018503610A5 (https=) | ||
| JP2021530444A5 (https=) | ||
| JP2023550149A5 (https=) | ||
| JP2024507810A5 (https=) | ||
| JP2021522246A5 (https=) | ||
| JP2018516936A5 (https=) | ||
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| JP2022502498A5 (https=) | ||
| JP2017537927A5 (https=) | ||
| JP2024016209A5 (https=) | ||
| JP2023537290A5 (https=) |